Finally Some Progress For Esophageal Cancer Patients– Two Immunotherapy Drugs Are Boosting Survival

Updated April 1st, 2021

Finally Some Progress For Esophageal Cancer Patients– Two Immunotherapy Drugs Are Boosting Survival

How immunotherapies are changing the treatment landscape for people with esophageal cancer, and how to know if you're a good candidate for one of these drugs.

NOW
PLAYING
If You're Over 65, Here's What You Need to Know About CAR T-Cell Therapy
NOW
PLAYING
CART T-Cell Therapy During the COVID-19 Pandemic: Is it Safe?
NOW
PLAYING
The Current and Future Role of Immunotherapy in Bladder Cancer
NOW
PLAYING
New Hope For Stomach Cancer: Immunotherapy Drug Opdivo Now Approved As a First Treatment
NOW
PLAYING
Some Melanoma Survivors See Long-Term Side Effects After Immunotherapy, Says New Study
NOW
PLAYING
'Raindrops Keep Fallin' on My Head' Singer B.J. Thomas, 78, Diagnosed with Stage 4 Lung Cancer; 'I Ask All of You for Your Prayers'

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.